| Today’s Big NewsMay 1, 2024 |
|
Therapeutic RNAs offer several advantages over other therapies due to their specificity and versatility, leading researchers to make great strides towards personalized medicine. Download the QPS white paper for insights into the future of RNA Therapies. 
|
|
| By Max Bayer Pfizer remains committed to developing an obesity treatment as rival pharmas rake in billions from their products. But just how it plans to make up for lost time is unclear. |
|
|
|
By Kevin Dunleavy Following the lead of Eli Lilly, Pfizer will establish a direct-to-consumer service, selling some of its medicines online and avoiding industry middlemen. The company plans to sell products such as its COVID treatment Paxlovid and a migraine nasal spray in this way, it told the Financial Times. |
By Fraiser Kansteiner WuXi Biologics has quietly pulled out of the 2024 BIO International Convention in June. The company's withdrawal from the convention comes at a point of heightened tension between Chinese biopharma service providers and certain U.S. lawmakers. |
By Angus Liu Facing a push for China-U.S. decoupling from Washington, the industry trade group BIO now wants to quantify the U.S.’s dependence on Chinese CDMOs through a survey. |
|
Tuesday, May 14, 2024 | 9:30am ET / 6:30am PT This webinar dives into patient-derived organoids viewed as the gold standard in bridging the gap between the lab and the clinic. The oncology portfolio allows researchers to incorporate patient relevance at every stage of the drug development pipeline - from target discovery and hit identification to lead validation and optimization. Register now. 
|
|
By Conor Hale Quest Diagnostics is building out its AI cancer pathology offerings through a multi-layered deal with PathAI—acquiring some assets and licensing out others. |
By James Waldron Eli Lilly’s explosion into the weight loss space is proving fruitful for shareholders, but it’s also providing fresh opportunities for biotechs looking for a Big Pharma partnership. |
By Max Bayer The three highest private biotech financings so far in 2024 totaled nearly $1.7 billion, led by Xaira Therapeutics’ $1 billion unveiling last week. One constant behind all three companies: ARCH Venture Partners. |
By Nick Paul Taylor Physicians are unequivocal about who is the big kahuna in the vaccine industry. Asked to rank vaccine manufacturers on five metrics, physicians produced a leaderboard that reads Pfizer, yawning gap, Merck. |
By Nick Paul Taylor Johnson & Johnson is unveiling a new look as part of its British birthday bash. One hundred years after setting up shop in the U.K., the drugmaker is refreshing its branding and visual identity as part of a global switch. |
By Zoey Becker The company's respiratory syncytial virus vaccine Arexvy takes some two-thirds of the RSV market share, GSK reported. Next up is a key FDA decision on the vaccine's use in the 50-to-59 age group, which would add another 50 million U.S. adults to its reach. |
By Andrea Park No 2 p.m. slump here—Moderna has launched a new video series to energize its social media followers’ midafternoon breaks. |
By Annalee Armstrong Astellas is in the market for a new CAR, and Poseida Therapeutics has a shiny convertible just the right size. The companies have signed an agreement, via Astellas’ subsidiary Xyphos Biosciences, to develop two cell therapy candidates for solid tumors. |
By Conor Hale Endomag's portfolio includes the grain-sized Magseed implant and the injectable Magtrace solution to identify breast cancer lesions and nearby lymph nodes for biopsy and surgery. |
By Nick Paul Taylor Aurinia Pharmaceuticals is using Lupus Awareness Month to get its message about screening and treatment to a wider audience. The drugmaker will play a part in meetings across May, including an event in New York where its celebrity spokesperson Toni Braxton will discuss life with lupus. |
Fierce podcasts Don’t miss an episode |
| This week on "Podnosis," Fierce Healthcare Senior Writer Anastassia Gliadkovskaya dives into the details of the innovation hub being built in New Jersey's SciTech City. |
|
|---|
|
|
|
Wednesday, May 22, 2024 | 11am ET / 8 am PT Learn GMP regulations in pharmaceutical storage at our upcoming webinar. Discover FDA requirements, including space validation, environmental controls, and risk mitigation. Explore services like aliquoting and cold chain transportation. Register now. 
|
|
Whitepaper This paper defines “digital companions” in biopharma, explores their value from the patient & company perspectives, & outlines a process for successfully fielding a new digital companion. Presented by: Blue Matter, strategic consultants in the life sciences |
Whitepaper Explore the complex considerations of vaccine development for influenza and COVID-19, including the challenges posed by viral evolution and the importance of ongoing research in this paper by vaccine expert, Dr. Lisa Kierstead. Sponsored by: PPD®️ Laboratory Services |
eBook To make every rare disease trial count, we design patient-centric, relevant strategies for sponsors and caregivers to produce impactful results every time. Sponsored by: Emmes Company |
Whitepaper Discover the secrets behind successful patient engagement Sponsored by: ProofPilot |
Whitepaper Antibody biomarkers are redefining precision medicine, from diagnosing diseases earlier to stratifying patients – download your FREE white paper today! Sponsored by: Sengenics Corporation LLC |
Whitepaper The use of prefilled syringes to administer biotherapeutics is beginning to gain traction because they offer a range of stability, efficacy, and patient safety benefits. Download this white paper to learn how Lonza has developed a novel workflow to ensure confidence regarding functionality in PFS and autoinjectors. Presented by Lonza |
eBook Unlock the future of monoclonal antibody (mAb) manufacturing with a complete guide to enhancing productivity and quality for exceptional outcomes. Sponsored by: Thermo Fisher Scientific |
Whitepaper This paper assesses the current state of the oncology market, reviewing key expectations for 2024. It addresses CAR-T therapies, KRAS, radiopharmaceuticals, & targeted protein degradation. Presented by Blue Matter, strategic consultants in the life sciences |
Whitepaper Choosing the right contract lab can help drug developers accelerate their timelines and generate cost-efficiencies. For insights into what to look for when selecting a GMP/CMC lab partner read this white paper which delves into a range of factors that can support your needs in both the short-term and in planning for the future. Sponsored by: PPD®️ Laboratory Services |
On Helix Date: 4 July 2024 - Location: Babraham Research Campus, Cambridge UK |
|
| |
|
